Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus.

Tuberculosis (Edinburgh, Scotland)·2024
Same author

Optimizing Virtual Health Technologies Through a Performance-based Readiness Model: Lessons From the Field Deployment of National Emergency Tele-Critical Care Network.

Military medicine·2023
Same author

Project APRED: A web-based data analytics platform for supporting community disaster resilience.

Journal of emergency management (Weston, Mass.)·2023
Same author

Knowledge graph analytics platform with LINCS and IDG for Parkinson's disease target illumination.

BMC bioinformatics·2022
Same author

TIGA: target illumination GWAS analytics.

Bioinformatics (Oxford, England)·2021
Same author

Netpredictor: R and Shiny package to perform drug-target network analysis and prediction of missing links.

BMC bioinformatics·2018
Same journal

Why Next-generation mechanistic models Will transform drug discovery: integrating efficacy and safety.

Expert opinion on drug discovery·2026
Same journal

Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.

Expert opinion on drug discovery·2026
Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational risk assessment.

Expert opinion on drug discovery·2026
Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026
Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026
Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Mining large heterogeneous data sets in drug discovery.

David J Wild1

  • 1Director of Cheminformatics Program, Assistant Professor of Informatics, Indiana Universtiy, School of Informatics and Computing, 901 E. 10th St., Bloomington, IN 47408, USA +1 812 856 1848 ; +1 608 541 5402 ; djwild@indiana.edu.

Expert Opinion on Drug Discovery
|March 14, 2013
PubMed
Summary
This summary is machine-generated.

Effective drug discovery relies on mining vast datasets from chemistry, biology, and pharmacology. Integrative data mining and semantic web techniques are crucial for uncovering novel associations across multiple sources.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Related Experiment Videos

Last Updated: May 13, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Area of Science:

  • Computational Chemistry
  • Bioinformatics
  • Pharmacology

Background:

  • Effective drug discovery necessitates searching and data mining of extensive information from diverse sources, including chemistry, biology, and pharmacology.
  • The proliferation of databases relevant to drug discovery presents both opportunities and challenges for researchers.

Purpose of the Study:

  • To review publicly available large-scale databases pertinent to drug discovery.
  • To describe data mining approaches applicable to these databases.
  • To discuss recent advancements in integrative data mining, including Semantic Web techniques, for identifying cross-source associations.

Main Methods:

  • Literature review of publicly available drug discovery databases.
  • Analysis of data mining techniques for large-scale datasets.
  • Exploration of integrative data mining strategies and Semantic Web applications.

Main Results:

  • Identification of key large-scale databases for drug discovery.
  • Overview of various data mining methodologies.
  • Demonstration of integrative approaches for multi-source data analysis.

Conclusions:

  • Future drug discovery data mining requires intelligent, semantic aggregation of information.
  • Advanced methods like intelligent agents and inference engines are essential for client applications.